Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Zhao MW et al. – On the basis of the results of this study and available information regarding the expected rate of spontaneous resolution, 30% verteporfin dose seems to be safe and effective in the treatment of acute central serous chorioretinopathy.

Related Articles

Peripheral Exudative Hemorrhagic Chorioretinopathy: A Clinical, Angiographic, and Histologic Study
American Journal of Ophthalmology, 10/07/09    Relevance Score: 83%

Standard-Fluence versus Low-Fluence Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Nonrandomized Clinical Trial
American Journal of Ophthalmology, 11/09/09    Relevance Score: 80%

Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy
Indian Journal of Ophthalmology, 11/02/09    Relevance Score: 80%

Smokestack leak in central serous chorioretinopathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 10/20/09    Relevance Score: 80%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address